Morphic Therapeutic to Present at the Jefferies Next Generation IBD Therapeutics Virtual Summit

Rhea-AI Summary

Morphic Therapeutic (NASDAQ: MORF) announced participation in the Jefferies Next Generation IBD Therapeutics Virtual Summit on September 23, 2020. The management team will engage in a panel discussion at 8:45 a.m. ET and present a company overview at 1:00 p.m. ET. A live webcast will be accessible via the Investor section of Morphic's website, with an archived replay available post-conference. Morphic specializes in developing oral therapies targeting integrins to treat serious chronic diseases, using its proprietary MInT technology platform in collaborations with major pharmaceutical firms.

WALTHAM, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment of serious chronic diseases, today announced two presentations at the Jefferies Next Generation IBD Therapeutics Virtual Summit. Members of the Morphic management team are scheduled to participate in a panel discussion at 8:45 a.m. ET on Wednesday, September 23, 2020, as well as present a company overview at 1:00 p.m. ET on the same day.

A live webcast of the company presentation will be available on the Investor section of Morphic’s website at https://www.morphictx.com. An archived replay will be available on the company’s website following the conference.

About Morphic Therapeutic

Morphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. In collaboration with AbbVie, Janssen and Schrödinger, Morphic is advancing its pipeline and discovery activities using its proprietary MInT technology platform which leverages the Company’s unique understanding of integrin structure and biology. For more information, visit www.morphictx.com.

Contacts

Morphic Therapeutic
Chris Erdman
chris.erdman@morphictx.com
617.686.1718

Media Contact
Tom Donovan, Ten Bridge Communications
tom@tenbridgecommunications.com
857.559.3397

FAQ

What is Morphic Therapeutic's participation in the Jefferies Summit 2020?

Morphic Therapeutic will participate in the Jefferies Next Generation IBD Therapeutics Virtual Summit on September 23, 2020.

When is Morphic Therapeutic's panel discussion at the Jefferies Summit?

The panel discussion is scheduled for 8:45 a.m. ET on September 23, 2020.

What time will Morphic Therapeutic present their company overview?

The company overview presentation by Morphic Therapeutic will take place at 1:00 p.m. ET on September 23, 2020.

Where can I watch Morphic Therapeutic's presentation live?

You can watch the live webcast of Morphic Therapeutic's presentation on the Investor section of their website.

What does Morphic Therapeutic focus on?

Morphic Therapeutic develops oral integrin therapies for serious chronic diseases, including autoimmune and cardiovascular diseases.